APELLIS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.37 USD | -1.66% |
|
+2.85% | -32.56% |
| May. 31 | Piper Sandler Starts Apellis Pharmaceuticals With Neutral Rating, $46 Price Target | MT |
| May. 24 | Apellis Pharmaceuticals, Sobi Say Pegcetacoplan Reduces Post-Transplant Kidney Diseases | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-06-04 | 2024-06-05 | 2024-06-06 | 2024-06-07 | |
|---|---|---|---|---|
| Last | 39.83 $ | 41.5 $ | 41.05 $ | 40.37 $ |
| Volume | 924 350 | 1 326 383 | 1 061 817 | 508 744 |
| Change | -0.70% | +4.19% | -1.08% | -1.66% |
| Opening | 39.72 | 40.06 | 41.65 | 40.81 |
| High | 40.19 | 41.69 | 41.66 | 41.78 |
| Low | 38.67 | 39.51 | 40.51 | 40.29 |
Performance
| 1 day | -1.66% | ||
| 1 week | +2.85% | ||
| Current month | +2.85% | ||
| 1 month | -4.56% | ||
| 3 months | -34.50% | ||
| 6 months | -35.64% | ||
| Current year | -32.56% | ||
| 1 year | -55.23% | ||
| 3 years | -30.49% | ||
| 5 years | +88.03% |
Volumes
marketsDaily volume
508 744
Estimated daily volume
508 744
Avg. Volume 20 sessions
1 212 049
Daily volume ratio
0.42
Avg. Volume 20 sessions USD
48 930 418.13
Record volume 1
30 877 960
Record volume 2
24 724 674
Record volume 3
21 426 108
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
4 899 527 455
Net sales (USD)
396 591 000
Number of employees
704
Sales / Employee (USD)
563 339
Free-Float
85.68 %
Free-Float capitalization (USD)
4 197 729 239
Average Daily Capital Traded
1%
Highs and lows
1 week
38.67
41.78
1 month
38.3543.99
Current year
38.2273.80
1 year
19.8394.75
3 years
19.8394.75
5 years
16.8594.75
10 years
11.4594.75
Indicators
Moving average 5 days
40.57
Moving average 20 days
41.39
Moving average 50 days
47.22
Moving average 100 days
55.18
Price spread / (MMA5)
+0.50%
Price spread / (MMA20)
+2.53%
Price spread / (MMA50)
+16.98%
Price spread / (MMA100)
+36.70%
STIM
RSI 9 days
46.51
RSI 14 days
43.03
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.66% | +2.85% | -32.56% | -55.23% | 4.9B | ||
| -0.17% | +3.18% | +0.82% | -5.48% | 91.94B | ||
| -1.32% | +2.74% | -1.32% | -4.46% | 38.74B | ||
| -2.83% | +0.22% | -12.88% | -27.02% | 32.82B | ||
| +0.08% | +1.05% | +64.77% | +51.76% | 26.66B | ||
| -0.20% | +7.49% | -16.31% | -12.54% | 15.32B | ||
| +1.28% | +2.37% | -5.78% | -3.82% | 13.3B | ||
| +0.44% | -2.26% | -11.38% | +10.21% | 11.65B | ||
| +13.03% | +44.70% | +173.10% | +474.79% | 10.37B | ||
| -1.29% | -6.55% | -49.84% | -31.03% | 10.12B | ||
| -2.63% | -0.50% | +5.24% | +26.24% | 9.06B | ||
| +0.14% | +1.70% | -16.26% | -1.92% | 7.46B | ||
| -0.20% | +1.74% | -4.48% | +4.79% | 7.22B | ||
| -0.38% | +10.06% | +0.81% | +21.31% | 7.09B | ||
| +1.50% | +4.65% | -7.12% | +7.06% | 6.77B | ||
| -0.09% | +0.21% | -39.51% | -17.68% | 6.14B | ||
| Average | +0.36% | +4.56% | +2.95% | +27.31% | ||
| Weighted average by Cap. | -0.14% | +3.68% | +5.37% | +14.62% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
2d8aedd2eaa101b98857e2e3471962ce.P3yH3GPn5gBk2YmEB8jq55HZQPzZcEosX2KbTHkDpsY.XQzhtBCsiEkhjOTcYfiniaarL5_0PxUbbVvIAQ1qnpdwM__oJtPRbjay-g
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 40.37 | 65,798 | 371,608 |
| 03:59:59 pm | 40.37 | 100 | 305,810 |
| 03:59:56 pm | 40.38 | 100 | 305,710 |
| 03:59:54 pm | 40.38 | 100 | 305,610 |
| 03:59:54 pm | 40.39 | 100 | 305,510 |
| 03:59:54 pm | 40.36 | 100 | 305,410 |
| 03:59:54 pm | 40.37 | 100 | 305,310 |
| 03:59:53 pm | 40.36 | 100 | 305,210 |
| 03:59:52 pm | 40.38 | 100 | 305,110 |
| 03:59:52 pm | 40.36 | 100 | 305,010 |
Monthly variations
Annual change
| 2024 | -32.56% | ||
| 2023 | +15.76% | ||
| 2022 | +9.37% | ||
| 2021 | -17.34% | ||
| 2020 | +86.81% | ||
| 2019 | +132.15% | ||
| 2018 | -39.22% | ||
| 2017 | +54.67% |
- Stock Market
- Equities
- APLS Stock
- Quotes Apellis Pharmaceuticals, Inc.
